Nelconil (Nitrendipine)

Nitrendipine, the active ingredient in Nelconil, is a calcium channel blocker presented as a tablet for oral use. It treats hypertension in adult patients by lowering elevated blood pressure.

GNH USA supplies Nelconil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nelconil, a dihydropyridine calcium channel blocker, is employed in the management of elevated arterial pressure.

- Hypertension: reduces systolic and diastolic blood pressure by relaxing vascular smooth muscle and decreasing peripheral resistance.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness or light‑headedness: related to blood pressure lowering. - Tachycardia: compensatory increase in heart rate. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Myocardial infarction: rare but possible in patients with coronary artery disease. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Allergic reaction: rash, pruritus, or anaphylaxis. - Angio‑edema: swelling of face, lips, or throat. - Arrhythmias: irregular heart rhythms in susceptible individuals.

Patients should be evaluated for factors that may influence safety and efficacy. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Hepatic impairment: use with caution, dose may need adjustment. - Elderly patients: start at lower dose and monitor for dizziness. - Concomitant antihypertensives: assess for additive blood‑pressure‑lowering effects. - CYP3A4 inhibitors: avoid strong inhibitors that can raise drug levels. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nitrendipine may interact with other medicines, altering its effect or safety profile.

Major Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase plasma concentrations. - Other potent vasodilators (e.g., nitroglycerin): risk of severe hypotension. - Grapefruit juice: can markedly raise drug levels.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance antihypertensive effect, watch electrolytes. - Beta‑blockers: additive blood‑pressure reduction. - NSAIDs: may blunt antihypertensive response. - Alcohol: can increase dizziness and hypotension. - Calcium supplements: may reduce absorption if taken simultaneously.